1,653
Participants
Start Date
April 14, 2021
Primary Completion Date
October 29, 2026
Study Completion Date
October 29, 2026
Pembrolizumab
Pembrolizumab 400 mg administered Q6W via IV infusion
Belzutifan
Belzutifan 120 mg administered QD via oral tablet
Pembrolizumab/Quavonlimab
Pembrolizumab/quavonlimab is a co-formulated product composed of pembrolizumab 400 mg in combination with quavonlimab 25 mg, administered Q6W via IV infusion
Lenvatinib
Lenvatinib 20 mg administered QD via oral capsule
National Taiwan University Hospital ( Site 4401), Taipei
Chang Gung Medical Foundation-Linkou Branch-Urology ( Site 4406), Taoyuan District
National Cheng Kung University Hospital ( Site 4404), Tainan City
Chang Gung Medical Foundation. Kaohsiung Branch ( Site 4405), Kaohsiung City
Manila Doctors Hospital ( Site 4601), Manila
Orszagos Onkologiai Intezet ( Site 2304), Budapest
Akershus universitetssykehus ( Site 2000), Lorenskog
Cardinal Santos Medical Center ( Site 4603), San Juan City
The Medical City ( Site 4602), Pasig
Sykehuset Østfold HF Kalnes ( Site 2003), Grålum
Vaal Triangle Oncology Centre ( Site 3010), Vereeniging
Macquarie University ( Site 4007), Macquarie University
Liverpool Hospital ( Site 4006), Liverpool
Wits Clinical Research ( Site 3012), Johannesburg
Sandton Oncology Medical Group PTY LTD ( Site 3000), Johannesburg
Herlev Hospital ( Site 1700), Herlev
Monash Health ( Site 4008), Clayton
Debreceni Egyetem Klinikai Kozpont ( Site 2301), Debrecen
Soerlandet sykehus HF Kristiansand ( Site 2007), Kristiansand
Odense University Hospital ( Site 1701), Odense
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 2300), Szolnok
Helse Bergen HF - Haukeland Universitetssykehus ( Site 2002), Bergen
Lyell McEwin Hospital ( Site 4004), Elizabeth Vale
Bekes Megyei Kozponti Korhaz - Pandy Kalman Tagkorhaza ( Site 2309), Gyula
Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 2308), Kecskemét
Cancer Care Langenhoven Drive Oncology Centre ( Site 3009), Port Elizabeth
Fiona Stanley Hospital ( Site 4009), Murdock
St. Olavs Hospital HF ( Site 2005), Trondheim
Cape Town Oncology Trials Pty Ltd ( Site 3006), Kraaifontein
Cancercare Rondebosch Oncology ( Site 3005), Rondebosch
Groote Schuur Hospital ( Site 3011), Cape Town
Markusovszky Egyetemi Oktatokorhaz ( Site 2303), Szombathely
Klinicki Bolnicki Centar Zagreb ( Site 3200), Zagreb
"Klinicki bolnicki centar Sestre milosrdnice ( Site 3201)", Zagreb
Sidney Kimmel Center for Prostate and Urologic Cancers ( Site 0055), New York
Charite Universitaetsmedizin Berlin ( Site 1301), Berlin
Ramathibodi Hospital. ( Site 4500), Bangkok
National Cancer Center ( Site 4202), Goyang-si
Siriraj Hospital ( Site 4501), Bangkok
R.J. Zuckerberg Cancer Center-Medical Oncology ( Site 0013), Lake Success
Taipei Veterans General Hospital ( Site 4402), Taipei
Institut Paoli Calmettes ( Site 1206), Marseille
Chernihiv Medical Center of Modern Oncology ( Site 2709), Chernihiv
Instituto Nacional de Cancerologia ( Site 0602), Mexico City
Roswell Park Cancer Institute ( Site 0032), Buffalo
Institut Català d'Oncologia (ICO) - Girona ( Site 1500), Girona
Klinicki centar Nis ( Site 3322), Niš
Cherkasy Regional Oncology Dispensary ( Site 2704), Cherkasy
Helios Kliniken Schwerin GmbH ( Site 1302), Schwerin
Ospedale San Raffaele-Oncologia Medica ( Site 1417), Milan
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 1409), Milan
TYKS ( Site 1802), Turku
Klinički Bolnički Centar Split ( Site 3202), Split
Institut za onkologiju Vojvodine ( Site 3311), Kamenitz
Trakya University Medical Faculty Balkan Oncology Hospital ( Site 2906), Edirne
CHU Jean Minjoz ( Site 1205), Besançon
Hospital Clinico San Carlos ( Site 1503), Madrid
Hospital Universitario 12 de Octubre ( Site 1505), Madrid
Hospital Universitario Virgen de la Victoria ( Site 1504), Málaga
Ralph H. Johnson VA Center ( Site 0073), Charleston
Emory University Winship Cancer Institute ( Site 0012), Atlanta
University Cancer & Blood Center, LLC ( Site 0057), Athens
Institut Claudius Regaud ( Site 1214), Toulouse
Advent Health Hematology & Oncology ( Site 0003), Orlando
TAYS ( Site 1801), Tampere
Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 2900), Istanbul
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2901), Istanbul
Chungnam National University Hospital ( Site 4205), Daejeon
Ege Universitesi Tip Fakultesi Hastanesi ( Site 2904), Izmir
Dokuz Eylul Universitesi Tip Fakultesi Hastanesi ( Site 2905), Izmir
Vanderbilt University Medical Center ( Site 0069), Nashville
University of Tennessee Medical Center Knoxville ( Site 0019), Knoxville
Hospital Universitario Marques de Valdecilla ( Site 1501), Santander
University of Mississippi Medical Center ( Site 0037), Jackson
Norton Cancer Institute - St. Matthews ( Site 0065), Louisville
Taichung Veterans General Hospital ( Site 4403), Taichung
Azienda Ospedaliero - Universitaria Policlinico di Modena ( Site 1404), Modena
Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0610), Guadalajara
Parkview Cancer Institute ( Site 0088), Fort Wayne
Henry Ford Hospital ( Site 0038), Detroit
ME І.І. Mechnykov Dnipro Regional Clinical Hospital ( Site 2710), Dnipropetrovsk
Clinical oncology dispensary of Dnipro ( Site 2700), Dnipro
Cancer & Hematology Centers of Western Michigan ( Site 0018), Grand Rapids
CHU Angers ( Site 1200), Angers
Hospital Kuala Lumpur ( Site 4301), Kuala Lumpur
Regions Hospital ( Site 0095), Saint Paul
HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0005), Saint Louis Park
Universiti Malaya Medical Centre ( Site 4300), Kuala Lumpur
Rush University Medical Center ( Site 0040), Chicago
Regional Oncology Center of Kharkiv ( Site 2708), Kharkiv
Reg. Clinical Center of Urology and Nephrology n.a. V. I. Shapoval ( Site 2715), Kharkiv
Institut Kanser Negara - National Cancer Institute ( Site 4302), Putrajaya
Clinique Ambroise Pare Beuvry ( Site 1213), Beuvry
I CAN Oncology SA de SV ( Site 0601), Monterrey
Fundacion Cardiovascular de Colombia ( Site 0506), Piedecuesta
Centro de Investigacion Clinica de Oaxaca ( Site 0605), Oaxaca City
CH Lyon Sud Hospices Civils de Lyon ( Site 1203), Pierre-Bénite
Ochsner Medical Center ( Site 0049), New Orleans
Azienda Ospedaliera Policlinico di Bari ( Site 1411), Bari
Kuopion Yliopistollinen Sairaala ( Site 1803), Kuopio
Universitaetsklinik fuer Urologie ( Site 1300), Tübingen
Hopital Tenon ( Site 1212), Paris
UTSW Medical Center ( Site 0015), Dallas
Hospital H+ Queretaro-Cuidados Oncológicos ( Site 0608), Querétaro City
Ivano-Frankivsk Regional Hospital-Urology department ( Site 2707), Ivano-Frankivsk
Ivano-Frankivsk Regional Oncology Clinical Dispensary ( Site 2711), Ivano-Frankivsk
Fakultni nemocnice Olomouc ( Site 2200), Olomouc
Lviv State Regional Oncological Center ( Site 2712), Lviv
Istituto Nazionale Tumori Fondazione Pascale ( Site 1412), Napoli
Hospital Sultan Ismail ( Site 4303), Johor Bahru
Centrum Onkologii im. Prof. Franciszka Lukaszczyka-Ambulatorium Chemioterapii ( Site 2420), Bydgoszcz
Clinique Francois Chenieux ( Site 1209), Limoges
Cedars Sinai Medical Center ( Site 0027), Los Angeles
UCLA Hematology Oncology Santa Monica ( Site 0048), Santa Monica
UC San Diego ( Site 0050), La Jolla
University of California Irvine ( Site 0029), Orange
Gustave Roussy ( Site 1207), Villejuif
Oregon Health & Science University ( Site 0071), Portland
Central Washington Health Services Association d/b/a Confluence Health ( Site 0061), Wenatchee
Cancer Hospital Chinese Academy of Medical Science-Oncology ( Site 6026), Beijing
Peking University First Hospital ( Site 6011), Beijing
Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000), Beijing
Administradora Country SA - Clinica del Country ( Site 0504), Bogotá
Instituto Nacional de Cancerología E.S.E. ( Site 0503), Bogotá
The Loginov Moscow Clinical Scientific Center ( Site 2604), Moscow
Klinicki centar Srbije. ( Site 3333), Belgrade
Moscow Oncological Clinical Dispensary #1 ( Site 2619), Moscow
Harbin Medical University Cancer Hospital-urology ( Site 6015), Harbin
Ivanovo Regional Oncology Dispensary ( Site 2615), Ivanovo
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 2617), Saint Petersburg
City clinical oncological dispensary ( Site 2605), Saint Petersburg
Renji Hospital Shanghai Jiao Tong University School of Medicine ( Site 6017), Shanghai
Sociedad de Oncología Y Hematología del Cesar S.A.S. ( Site 0505), Valledupar
Shanghai Tenth People's Hospital ( Site 6023), Shanghai
S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 2501), Craiova
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S, Nanjing
The Second Affiliated Hospital of Soochow University-Urology ( Site 6025), Suzhou
The First Afflilated Hospital of Bengbu Medical College-Urology Surgery ( Site 6041), Bengbu
Tianjin Medical University Cancer Institute and Hospital ( Site 6029), Tianjin
The Second Hospital of Tianjin Medical University ( Site 6032), Tianjin
Policlinica Oncomed SRL ( Site 2506), Timișoara
The First Affiliated Hospital, Zhejiang University ( Site 6024), Hangzhou
The First Hospital of Jiaxing ( Site 6033), Jiaxing
Ningbo First Hospital-Urology ( Site 6028), Ningbo
The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 6021), Wenzhou
The First Affiliated Hospital of Nanchang University ( Site 6019), Nanchang
Jiangxi Provincial Cancer Hospital ( Site 6042), Nanchang
The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 6038), Fuzhou
The First Affiliated hospital of Xiamen University-Urology ( Site 6001), Xiamen
Chongqing University Cancer Hospital ( Site 6009), Chongqing
Xiangya Hospital Central South University ( Site 6034), Changsha
Hunan Cancer Hospital ( Site 6020), Changsha
Wuhan Union Hospital ( Site 6002), Wuhan
Henan Cancer Hospital-Urology ( Site 6006), Zhengzhou
Spitalul Judetean de Urgenta Alba Iulia ( Site 2502), Alba Iulia
SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 6003), Guangzhou
The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 6036), Guangzhou
Guangzhou First People's Hospital ( Site 6007), Guangzhou
Sun Yat-sen Memorial Hospital, Sun Yat-sen University-Urology Surgery ( Site 6005), Guangzhou
FBHI Privolzhsky District Medical Center of the FMBA ( Site 2611), Nizhny Novgorod
Nizhniy Novgorod Region Oncology Dispensary ( Site 2621), Nizhny Novgorod
West China Hospital Sichuan University-Urology Surgery ( Site 6016), Chengdu
Altay Regional Oncology Dispensary ( Site 2610), Barnaul
Oncólogos del Occidente S.A ( Site 0501), Pereira
Krasnoyarsk Regional Clinical Oncological Dispensary ( Site 2609), Krasnoyarsk
The First Affiliated Hospital of Xi'an Jiaotong University ( Site 6014), Xi'an
IC La Serena Research ( Site 0403), La Serena
Servicios Medicos Urumed ( Site 0405), Rancagua
Centro Investigacion Cancer James Lind ( Site 0402), Temuco
Fundacion Arturo Lopez Perez ( Site 0400), Santiago
Bradfordhill-Clinical Area ( Site 0401), Santiago
Centro Avançado de Tratamento Oncológico- CENATRON-Clinical Research ( Site 0303), Belo Horizonte
The University of Alabama at Birmingham ( Site 0010), Birmingham
Hartford Hospital ( Site 0024), Hartford
New England Cancer Specialists ( Site 0082), Scarborough
Massachusetts General Hospital ( Site 0094), Boston
Beth Israel Deaconess Medical Center ( Site 0089), Boston
Dana Farber Cancer Institute ( Site 0093), Boston
Lahey Hospital & Medical Center ( Site 0090), Burlington
Dartmouth Hitchcock Medical Center ( Site 0075), Lebanon
Oncocentro Ceara ( Site 0309), Fortaleza
Centro de Pesquisas Clinicas em Oncologia ( Site 0306), Cachoeiro de Itapemirim
Liga Norte Riograndense Contra o Cancer ( Site 0308), Natal
Hospital de Clinicas de Porto Alegre ( Site 0310), Porto Alegre
Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0302), São Paulo
BP - A Beneficencia Portuguesa de São Paulo-Medical Oncology ( Site 0300), São Paulo
A.C. Camargo Cancer Center ( Site 0301), São Paulo
Tom Baker Cancer Centre ( Site 0119), Calgary
BC Cancer - Vancouver Center ( Site 0120), Vancouver
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0117), Hamilton
Sunnybrook Research Institute ( Site 0116), Toronto
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0, Québec
Instituto de Cancerología S.A Clínica de las Americas (ICCLA) ( Site 0500), Medellín
Clinica de la Costa S.A.S. ( Site 0502), Barranquilla
Masarykuv onkologicky ustav ( Site 2203), Brno
Nemocnice AGEL Novy Jicin a.s. ( Site 2202), Nový Jičín
Fakultni nemocnice Ostrava ( Site 2208), Ostrava
Fakultni nemocnice u sv. Anny v Brne ( Site 2205), Brno
Fakultni Thomayerova nemocnice ( Site 2201), Prague
2 LF UK a FN Motol ( Site 2207), Prague
HYKS ( Site 1800), Helsinki
Centro Medico Integral de Cancerologia CEMIC ( Site 0701), Salcajá
Oncomedica ( Site 0700), Guatemala City
Grupo Angeles SA ( Site 0705), Guatemala City
Sanatorio Nuestra Senora del Pilar ( Site 0702), Guatemala City
Medi-K Cayala ( Site 0703), Guatemala City
Centro Regional de Sub Especialidades Medicas SA ( Site 0704), Quetzaltenango
Beaumont Hospital ( Site 6101), Dublin
Tallaght University Hospital ( Site 6100), Dublin
Fondazione Policlinico Universitario A. Gemelli ( Site 1414), Rome
Azienda Ospedaliera S. Maria di Terni ( Site 1410), Terni
Fujita Health University ( Site 5003), Toyoake
Chiba cancer center ( Site 5021), Chiba
National Cancer Center Hospital East ( Site 5000), Kashiwa
Ehime University Hospital ( Site 5020), Tōon
Sapporo Medical University Hospital ( Site 5008), Sapporo
Hokkaido University Hospital ( Site 5013), Sapporo
Kanagawa cancer center ( Site 5016), Yokohama
Nara Medical University Hospital ( Site 5002), Kashihara
Kindai University Hospital- Osakasayama Campus-Urology ( Site 5010), Sayama
Osaka University Hospital ( Site 5012), Suita
Saitama Medical University International Medical Center ( Site 5015), Hidaka
Hamamatsu University School of Medicine University Hospital ( Site 5004), Hamamatsu
Tokyo Medical And Dental University Medical Hospital-Urology ( Site 5009), Bunkyō
Toranomon Hospital ( Site 5001), Minato-ku
Toyama University Hospital ( Site 5014), Toyoma
Kyushu University Hospital ( Site 5005), Fukuoka
Kumamoto University ( Site 5022), Kumamoto
Niigata University Medical & Dental Hospital ( Site 5024), Niigata
Okayama University Hospital ( Site 5017), Okayama
Tokushima University Hospital-Department of Urology ( Site 5019), Tokushima
Nippon Medical School Hospital ( Site 5006), Tokyo
Tokyo Women's Medical University Adachi Medical Center ( Site 5023), Tokyo
Keio university hospital ( Site 5011), Tokyo
Oslo Universitetssykehus Radiumhospitalet ( Site 2001), Oslo
Przychodnia Lekarska KOMED ( Site 2419), Konin
Uniwersytecki Szpital Kliniczny w Poznaniu ( Site 2406), Poznan
Radomskie Centrum Onkologii ( Site 2418), Radom
Luxmed Onkologia sp. z o. o. ( Site 2412), Warsaw
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 2405), Warsaw
Szpital Wojewodzki im. Mikolaja Kopernika ( Site 2407), Koszalin
S.C.Focus Lab Plus S.R.L ( Site 2503), Bucharest
Univ. Pretoria and Steve Biko Academic Hospitals ( Site 3002), Pretoria
Life Wilgers Hospital ( Site 3004), Pretoria
Mary Potter Oncology Centre, Little Company of Mary Hospital ( Site 3001), Pretoria
Korea University Anam Hospital ( Site 4206), Seoul
Seoul National University Hospital ( Site 4201), Seoul
Severance Hospital Yonsei University Health System ( Site 4204), Seoul
Asan Medical Center ( Site 4203), Seoul
Samsung Medical Center ( Site 4200), Seoul
Instituto Catalan de Oncologia - ICO ( Site 1502), L'Hospitalet de Llobregat
Lanssjukhuset Ryhov ( Site 2103), Jönköping
Karolinska Universitetssjukhuset Solna ( Site 2100), Stockholm
Akademiska Sjukhuset ( Site 2105), Uppsala
Norrlands Universitetssjukhus ( Site 2106), Umeå
Sahlgrenska Universitetssjukhuset ( Site 2102), Gothenburg
Ankara Universitesi Tip Fakultesi ( Site 2902), Ankara
Hacettepe Universitesi Tıp Fakultesi ( Site 2903), Ankara
Kyiv City Clinical Oncology Center ( Site 2706), Kyiv
Addenbrookes Hospital ( Site 3110), Cambridge
Barts Health NHS Trust - St Bartholomew s Hospital ( Site 3116), London
Mount Vernon Cancer Centre ( Site 3101), Northwood
Eisai Inc.
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY